BGene offers turnkey solutions for strain development challenges in various biotech industries, using white biotechnology and synthetic biology. Their proprietary COLIBELT platform allows for precise gene insertion and modification without leaving any genomic scars or antibiotic resistance. They have also developed the UNBELT platform to extend their capabilities to other microbes. BGene aims to develop sustainable and resilient production methods for high-value biobased molecules, leveraging their expertise in molecular biology, microbiology, biochemistry, process engineering, and computer sciences. They cater to diverse markets such as food, pharma, cosmetics, chemistry, and environment with their cutting-edge bioprocesses.